Oscar Health Inc. [OSCR] stock for 56,657 USD was sold by Quane Alessandrea C.

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Oscar Health Inc. shares valued at $56,657 were sold by Quane Alessandrea C. on Jun 06. At $5.01 per share, Quane Alessandrea C. sold 11,300 shares. The insider’s holdings dropped to 131,018 shares worth approximately $0.77 million following the completion of this transaction.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Also, Blackley Richard Scott sold 19,546 shares, netting a total of over 98,002 in proceeds. Following the sale of shares at $5.01 each, the insider now holds 264,307 shares.

Before that, Weaver Dennis had sold 1,548 shares from its account. In a trade valued at $7,255, the Chief Clinical Officer traded Oscar Health Inc. shares for $4.69 each. Upon closing the transaction, the insider’s holdings decreased to 1,548 shares, worth approximately $0.11 million.

As published in a research note from BofA Securities on June 15, 2022, Oscar Health Inc. [OSCR] has been rated down from a Neutral to an Underperform and the price target has been revised to $4.50 from $6. This represents a -31.11% premium over Thursday’s closing price. Analysts at BofA Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in late May. As of February 14, 2022, Goldman has decreased its “Neutral” rating to a “Sell” for OSCR. Earlier on January 06, 2022, Wells Fargo downgraded its rating. Their new recommendation was “an Equal weight” for OSCR stock which previously was a “an Overweight”.

Analyzing OSCR’s Price Performance

On Thursday, Oscar Health Inc. [NYSE: OSCR] rose 0.34% to $5.90. The stock’s lowest price that day was $5.83, but it reached a high of $6.00 in the same session. During the last five days, there has been a surge of approximately 10.49%. Over the course of the year, Oscar Health Inc. shares have dropped approximately -24.84%. Shares of the company reached a 52-week high of $10.52 on 03/30/22 and a 52-week low of $3.89 on 06/15/22. A 50-day SMA is recorded $4.87, while a 200-day SMA reached $7.98. Nevertheless, trading volume fell to 1.02 million shares from 1.33 million shares the previous day.

Support And Resistance Levels for Oscar Health Inc. (OSCR)

According to the 24-hour chart, there is a support level at 5.82, which, if violated, would cause prices to drop to 5.74. In the upper region, resistance lies at 5.99. The next price resistance is at 6.08. RSI (Relative Strength Index) is 68.56 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.42, which suggests the price will decrease in the coming days. Percent R is at 8.30%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Is Oscar Health Inc. subject to short interest?

Stocks of Oscar Health Inc. saw a sharp rise in short interest on Jul 14, 2022 jumping by 1.77 million shares to 10.32 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 8.55 million shares. A jump of 17.15% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.42 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.42.

Which companies own the most shares of Oscar Health Inc. (OSCR)?

According to Baillie Gifford & Co. filings, the company currently owns 21,381,904 shares, which is about 12.16% of the total OSCR shares outstanding. The investor’s shares have plunged by -1,942,592 from its previous 13-F filing of 23324496.0 shares. With the completion of the buy transaction, Southeastern Asset Management, In’s stake is now worth $47,374,206. The Vanguard Group, Inc. reduced a -3.29% interest valued at $38.02 million while Wellington Management Co. LLP sold a -108,143 stake. A total of 2,751,000 shares of Oscar Health Inc. were sold by Capital Research & Management Co during the quarter, and 1,876,638 were bought by Millennium Management LLC. In its current portfolio, Tiger Global Management LLC holds 2,127,454 shares valued at $9.04 million.

In terms of Oscar Health Inc. share price expectations, FactSet research, analysts set an average price target of $8.21 in the next 12 months, up nearly 36.05% from the previous closing price of $5.88. Analysts anticipate Oscar Health Inc. stock to reach $12.00 by 2022, with the lowest price target being $4.50. In spite of this, 7 analysts ranked Oscar Health Inc. stock as a Hold at the end of 2022. On December 14, 2021, Goldman assigned a price target of “a Sell” to the stock and initiated coverage with a $6.50.

LEAVE A REPLY

Please enter your comment!
Please enter your name here